Literature DB >> 10896365

Vitrectomy for macular edema combined with retinal vein occlusion.

N Tachi1, Y Hashimoto, N Ogino.   

Abstract

This study was performed in order to evaluate the effect of vitrectomy in eyes with retinal vein occlusion associated with macular edema. Twenty-nine years eyes (27 patients) with branch retinal vein occlusion (BRVO), and 14 eyes (13 patients) with central retinal vein occlusion (CRVO) both associated with macular edema underwent phacoemulsification, intraocular lens implantation, pars plana vitrectomy and peeling of the posterior hyaloid membrane. Follow-up ranged from 12 to 32 months. Macular edema was reduced, and visual improvement was observed (p < 0.0001 in BRVO, p = 0.0257 in CRVO, paired t-test). Visual outcome was better in eyes with better visual acuity before surgery. Early vitrectomy may be recommended for retinal vein occlusion associated with macular edema.

Entities:  

Mesh:

Year:  1999        PMID: 10896365     DOI: 10.1023/a:1002432032354

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  2 in total

1.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.

Authors:  N Tachi; N Ogino
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

Review 2.  Surgical management of macular edema.

Authors:  N Tachi
Journal:  Semin Ophthalmol       Date:  1998-03       Impact factor: 1.975

  2 in total
  30 in total

1.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

Authors:  M T Cahill; P K Kaiser; J E Sears; S Fekrat
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group.

Authors:  Seiyo Harino; Kenichiro Bessho; Teruyo Kida
Journal:  Jpn J Ophthalmol       Date:  2012-02-23       Impact factor: 2.447

3.  Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.

Authors:  Rika Yamada; Akihiro Nishida; Masataka Shimozono; Takanori Kameda; Noriko Miyamoto; Michiko Mandai; Yasuo Kurimoto
Journal:  Jpn J Ophthalmol       Date:  2015-09-03       Impact factor: 2.447

Review 4.  Can the integrity of the photoreceptor layer explain visual acuity in branch retinal vein occlusion?

Authors:  Naoichi Horio
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

5.  Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study.

Authors:  Francisco J Ascaso; Esteban Padgett; Esther Núñez; Laura Villén; Andrzej Grzybowski; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03       Impact factor: 3.117

6.  Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion.

Authors:  Ryo Terao; Kentaro Yuda; Kayo Kure; Tatsuya Inoue; Hiroshi Ohtsu; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-01-10       Impact factor: 2.447

7.  Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  Int Ophthalmol       Date:  2011-11-22       Impact factor: 2.031

8.  Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.

Authors:  Jérôme Charbonnel; Agnès Glacet-Bernard; Jean-François Korobelnik; Emilienne Nyouma-Moune; Constantin J Pournaras; Joseph Colin; Gabriel Coscas; Gisèle Soubrane
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

9.  Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  BMC Ophthalmol       Date:  2010-04-29       Impact factor: 2.209

10.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.